Micron Bounces Back While Shorts Continue to Exit

Micron Technology gained 3.6% this week to close at $928.76, outperforming a median decline of 2.8% among its closest semiconductor peers, even as the stock remains 15% below its October 1 peak of $1,097.

The recovery is notable for what did not happen alongside it. Short sellers have been covering, not adding. Short interest dropped 8.8% over the week to 23.2 million shares, now 2.1% of the free float. That marks a sustained retreat: bears held more than 29.7 million shares in late September. Since then, roughly 6.5 million shares of short exposure have been closed out. The borrow market reflects this disengagement entirely. Availability is at the data ceiling, with more than a billion shares available to lend and only a fraction lent out. Cost to borrow nearly doubled over the week to 0.25%, but that number remains trivially low in absolute terms. There is no squeeze, no crowding, and no structural pressure forming in the lending market.

Options positioning has shifted mildly in favour of calls. The put/call ratio fell to 0.98, a fraction below its 20-day average of 1.01 and close to the 52-week low of 0.96. That is a modest move, but the direction is consistent with the short-covering trend. The market is not building downside protection at current levels.

The Street remains uniformly bullish, though the consensus target of $1,562 implies roughly 68% upside from current levels, a gap that has been wide since the October selloff began and has not tightened. Rosenblatt reiterated Buy with a $1,900 target on October 22. Needham did the same at $1,650. Morgan Stanley holds Overweight at $1,200. The outlier is DA Davidson, which raised its target to $3,000 on October 7, citing AI-driven memory demand. The bull case centres on Micron's position in high-bandwidth memory, with 1-gamma in high-volume manufacturing and 1-delta expected to deliver meaningful bit-density gains. Free cash flow generation has been substantial: 4QF26 adjusted free cash flow came in at $33.2 billion. The bear case focuses on cyclical risk. Any return to oversupply in DRAM or NAND could push cash costs above selling prices rapidly, and execution risk on technology transitions is real. Valuation, at a trailing PE of 4.6x and EV/EBITDA of 3.5x, looks undemanding, though the 30-day decline in the PE multiple of 1.4x points reflects the October price weakness rather than any estimate revision. EPS momentum over 90 days ranks in the 96th percentile of the ORTEX universe, and earnings yield ranks at the 92nd percentile.

The peer comparison this week is telling. While MU gained 3.6%, LRCX fell 8.6% and AMAT dropped 2.2%. AMD was the exception, up 4.8%, broadly in line with Micron. The divergence from LRCX in particular is worth noting: the two stocks have an 82% correlation over time, so a near-13-point spread in weekly performance is wider than usual. Micron's move looks more idiosyncratic this week than it has for most of October.

Institutional holders added modestly in the quarter to September 30. BlackRock increased its position by 1.7 million shares to 104.8 million, keeping it the largest registered holder at 9.3% of shares outstanding. JP Morgan Asset Management made the largest proportional addition among top holders, adding 8 million shares to reach 18.2 million. T. Rowe Price added 9.3 million shares, taking its stake to 15.3 million. These are not activist moves, but the direction of institutional flow is consistently additive. On the insider side, the Chief Technology and Product Officer sold 28,500 shares on October 16 at around $900, all under a pre-arranged 10b5-1 plan. Planned sales of that kind carry limited informational weight.

The next earnings date is December 16. Between now and then, the question is whether the stock can close the gap to the October peak at $1,097 without a catalyst. The October selloff produced no short-seller response, and the current rally has not either. The short score has eased this week to 28.7, consistent with the lighter positioning. What to watch: whether short interest continues its downward path as the price recovers, and whether any analyst meaningfully revises estimates ahead of the December print.